Prevention of liver cancer and cirrhosis by vaccines

被引：5

作者：

Prince, AM

机构：

来源：

CLINICS IN LABORATORY MEDICINE | 1996年 / 16卷 / 02期

关键词：

D O I：

10.1016/S0272-2712(18)30281-6

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Existing vaccines for hepatitis B virus (HBV) are described, and their advantages and efficacies are compared. The possible advantages of including PreS determinants are discussed. Use of HBV vaccines, although increasing, remains at a disappointing level if worldwide eradication of HBV-associated chronic liver disease is to be achieved. The evolution of vaccine-resistant HBV strains is discussed. Vaccines need to be developed for hepatitis C virus as well, and impediments and solutions to their development are reviewed.

引用

页码：493 / +

页数：1

共 80 条

[31]

KURTZ JB, 1989, LANCET, V1, P451

[32]

LIANG TJ, 1993, HEPATOLOGY, V18, P1326, DOI 10.1016/0270-9139(93)90219-D

[33]

Lieming Ding, 1993, Clinical Infectious Diseases, V17, P475

[34] IMMUNOGENICITY AND EFFICACY TESTING IN CHIMPANZEES OF AN ORAL HEPATITIS-B VACCINE BASED ON LIVE RECOMBINANT ADENOVIRUS [J].